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STUDIES OF THE MACROPHAGE COMPLEMENT RECEPTOR
Alteration of Receptor Function upon Macrophage Activation*
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(From The Rockefeller University, New York 10021)
Macrophages possess on their plasma membranes receptors for the Fc portion
of IgG and for the third complnent of complement (1,2) . These receptors are
important in the performance of some of the functions of these cells . The Fc
receptors mediate both attachment and ingestion of IgG-coated particles (3,4) .
However, the complement receptors of mouse peritoneal macrophages and of
human and rabbit alveolar macrophages mediate binding of C3-coated particles
to the macrophage surface but do not appear to mediate ingestion of these
particles (3,5,6) .
In several experimental systems, immunization or chronic intracellular infection has
been shown to alter certain functions of the immunized or infected animal's macrophages
(7-13) . Intraperitoneal injection ofsome foreign substances such as thioglycollatemedium
and bacillus Calmette-Guérin (BCG)' effects functional changes in the animal's peri-
toneal macrophages similar to those changes induced by immunization or intracellular in-
fection . Macrophages from such animals are termed activated macrophages . They spread
more readily on glass ; contain more mitochondria, lysosomes, and lysosomal enzymes ;
demonstrate increased spontaneous and postphagocytic glucose carbon-1 oxidation ; and
possess greater phagocytic, microbicidal, and microbistatic activity than their nonacti-
vated counterparts (7-13) . A qualitative difference in enzyme function between activated
and nonactivated macrophages was recently demonstrated by Unkeless et al . (14) . They
found that macrophages from mice injected intraperitoneally with thioglycollate medium
produce and secrete a neutral protease, plasminogen activator, while macrophages from
control mice do not .
In this paper, we present the results of our studies of the functions of the Fc
receptors and complement receptors of activated and nonactivated mouse peri-
toneal macrophages . We find that the quantity of ingestion mediated by the Yc
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`Abbreviations used in this paper: BCG, bacillus Calmette-Guérin ; E, sheep erythrocytes ; E(IgG),
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receptors is greater in activated than in nonactivated macrophages. The
complement receptors of nonactivated macrophages mediate only particle
binding to the macrophage surface while the complement receptors of activated
cells mediate both attachment and ingestion of complement-coated particles.
Materials and Methods
Animals. Mouse erythrocytes and peritoneal macrophages were obtained from Swiss mice
maintained at The Rockefeller University, N.Y. C5-deficient mouse serum was prepared from a
C5-deficient strain of AKR mice (Jackson Laboratories, Bar Harbor, Maine) .
Erythrocytes. Sheep erythrocytes (E) in Alsever's solution (Animal Blood Center, Syracuse,
N.Y.) were washed three times in PD (solution "a" of Dulbecco's phosphate-buffered saline (PBS)
(15)] and suspended in medium 199 (Microbiological Associates, Bethesda, Md.) or in Veronal-buff-
ered glucose containing Ca++, Mg++, and 0.1% gelatin (VBG) (16).
Macrophage activator. Brewer thioglycollate medium was obtained from Difco Laboratories,
Detroit, Mich., anda4.05% aqueous solution prepared according to themanufacturer's instructions .
Macrophages . The methods for harvesting and maintaining mouse peritoneal macrophages were
those of Cohn and Benson (17), as previously modified (18). Cells were cultivated for 24-48 h in
medium 199 with 20% heat-decomplemented (56°C, 30 min) fetal bovine serum (Grand Island
Biological Co., Grand Island, N.Y.), 100 U/ml of penicillin, and 100 gg/ml of streptomycin. In some
experiments, mice were injected intraperitoneally with 1 ml of Brewer thioglycollate medium 4days
before their peritoneal macrophages were harvested. Macrophages from these animals are designated
activated. Latex beads, 1.1 k in diameter (Dow Chemical Co., Midland, Mich.) were washed three
times in PD, suspended in PD at a concentration of 6 x 10° particles/ml, and stored at 4°C.
Sera.
￿
5 ml of normal rabbit serum was adsorbed at 4°C for 2h with 10'° mouse erythrocytes. The
adsorbed serum was frozen at -70°C and used as a source of complement for cytotoxic assays.
Serum was prepared from C5-deficient AKR mice and stored immediately in 0.2 ml aliquots at
-70°C. It served as asource of C1423 in all experiments involving theuse of complement-coated E.
Antisera and Immunoglobulin Fractions
RABBrr ANTIMOUSE MACROPHAGE IgG.
￿
Rabbit antimouse macrophage serum, prepared as previously
described (18,19), was chromatographed on DEAE cellulose. Theresulting IgG fraction wasdialyzed
against PBS, concentrated by vacuum dialysis, Millipore filtered (0.45 upore size), andstored at 4°C.
Theprotein concentration of this IgG fraction was 12 mg/ml; it agglutinated mouse erythrocytes at a
dilution of 1:500.
RABBIT ANTIMOUSE MACROPHAGE F(ab'),. The F(ab'), fragment of rabbit antimouse
macrophage IgG was prepared by pepsin digestion, using the method of Nisonoff (20), as previously
described (18). The protein concentration of this F(ab'), fraction was 3mg/ml; it agglutinated mouse
erythrocytes at a dilution of 1 :32.
Sheep IgG prepared against rabbit F(ab'), (SAR IgG) was prepared and purified as previously
described (18) . The protein concentration of SAR IgG was 28 mg/ml.
Rabbit antisheep E IgG (lot no. 10154), at a concentration of 5 mg/ml was obtained from Cordis
Laboratories, Miami, Fla. It agglutinated sheep E at a dilution of 1 :3,000.
Rabbit antisheep E IgM (lot no. 30704), at a concentration of 350 Ag/ml, was also obtained from
Cordis Laboratories. It agglutinated sheep E at a dilution of 1 :320.
Preparation of Immune Complexes .
￿
1 ml of 5% (vol/vol) E in medium 199 was incubated with
either 125 ug of rabbit antisheep E IgG or 13 Ag of rabbit antisheep E IgM for 15 min at 37°C . The
suspensions were centrifuged for 5 min at 750 g and the pellets suspended to 0.5% in medium 199.
These preparations (0.5% E coated with anti-E IgG or with anti-E IgM) are designated E(IgG) and
E(IgM), respectively.
Preparation of Complement-Coated Immune Complexes . Portions of 5% E(IgG) and E(IgM)
were suspended in VBG and mixed with an equal volume of a 1:10 dilution of freshly thawed
C5-deficient AKRmouseserum in VBG. Themixtures were incubated for 10 minat 37°C and washed
twice by centrifugation for 5 min at 750 g. The pelleted erythrocytes were suspended to 0.5% in
medium 199. These preparations [0.5% complement-coated E(IgG) and 0.5% complement-coated1280
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E(IgM)1 are designated E(IgG)C and E(IgM)C, respectively . VBG and all erythrocyte preparations
were made fresh on the day of an experiment .
Trypsin Treatment of Macrophages .
￿
Trypsin from bovine pancreas, Type III, no . T-8253, was
obtained from Sigma Chemical Co ., St . Louis, Mo . Macrophage monolayers were incubated for 30
min at 37°C with 1 mg/ml of trypsin in medium 199. Cover slipswere washed twice with 1 mg/ml of
ovomucoid trypsin inhibitor (Worthington Biochemical Corp ., Freehold, N. J.) in medium 199 to
terminate trypsin digestion .
Phase-Contrast andElectron Microscopy .
￿
Cover slip cultures were fixedwith glutaraldehyde and
examined by phase-contrast and electron microscopy as previously described (18) . Cells were
processed for electron microscopy as described (21, 22) and examined in a Siemens Elmiskop 1A
(Siemens Corp ., Medical Industrial Groups, Iselin, N.J .) .
Assay System . Macrophage monolayers were cultivated for 24-48 h on 13-mm diameter glass
cover slips . Cover slips were washed with medium' and covered with either medium or 0.05 ml of
antimacrophage IgG (6 lug protein) or antimacrophage : F(ab'), (6 lag protein) for 2 h at 37°C. After
washing, 2 ml of medium and 0.2 ml of one of thevarious erythrocyte preparations or latex particles
were added to each 35 mm petri dish, and incubation was continued for30 minat 37°C . Preparations
were fixed and examined . At least three separate experiments, performed in duplicate, are
represented by each value presented . At least 100 macrophages were evaluated for each determina-
tion .
In studies examining complement-mediated macrophage lysis, monolayers were incubated with
either medium alone, antimacrophage IgG, or antimacrophage F(ab') 2 , as above . Some macrophage
preparations were incubated with SARIgGor with antimacrophage F(ab') z and then with SARIgG.
The monolayers were then washed and incubated with 5% (vol/vol) freshly thawed rabbit serum (a
source of hemolytic complement) in medium for 30 min at 37°C and the percentage of macrophages
lysed determined by phase-contrast microscopy and by trypan blue exclusion .
Presentation of Results .
￿
The data from experiments examining the interaction of macrophages
with thevarious erythrocyte preparations are presented as follows : percent ingestion or attachment is
the percentage of macrophageswith erythrocytes ingested or attached . Ingestion or attachment index
is the percentage of macrophages which ingested or attached erythrocytes x average number of
erythrocytes ingested or attached per macrophage .
Miscellaneous .
￿
Hemagglutination titers of IgG, IgM, and F(ab'), preparations were determined
as previously described (18) . Protein determinations were performed by the method of Lowry et al .
(23), using bovine serum albumin as a standard . VBG was prepared as described by Rapp and Borsos
Results
Attachment and Ingestion of Sensitized Sheep Erythrocytes by Nonactiuated
Macrophages . The attachment and ingestion indices obtained when various
preparations of sheep erythrocytes were incubated with 24 h explanted nonac-
tivated mouse peritoneal macrophages are shown in Fig . 1 . NeitherE nor E(IgM)
were bound or ingested by these macrophages; E(IgM)C were attached but were
not ingested . The usual period of incubation of the various erythrocyte
preparations with macrophages was 30 min; prolonging the incubation period to 3
h did not produce an appreciable change in the number of erythrocytes attached
or ingested . Similar experiments were performed with macrophages cultivated
for 2, 48, and 72 h, and, in all cases, E(IgM)C attached to the macrophageplasma
membrane but were not ingested in significant numbers. To confirm that
E(IgM)C were not ingested, we incubated some preparations with 0.83%
ammonium chloride just before fixation . Incubation with ammonium chloride
causes lysis of extracellular erythrocytes, has no effect upon the macrophages or
their content of phagocytized erythrocytes, and allows the intracellular erythro-
'Throughout this paper the term "medium" refers to medium 199.CELSO BIANCO, FRANKM . GRIFFIN, ANDSAMUEL C . SILVERSTEIN
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FIG . 1 . Attachment and ingestion of preparations of sensitized sheep erythrocytes by
nonactivated macrophages. The bars for attachment represent only thosemacrophageswhich
have attached but not ingested erythrocytes . Lines represent thestandard errors of themeans.
cytes to be counted without interference by extracellular erythrocytes . Virtually
all erythrocytes in these preparations were lysed by ammonium chloride
treatment, indicating that E(IgM)C were not ingested by macrophages. Addi-
tional confirmation was obtained by examining parallel cultures by electron
microscopy . E(IgG) were avidly ingested ; the addition of mouse complement to
these preparations [E(IgG)C J did not significantly change the fate of these
sensitized erythrocytes .
It should be noted that the presence of small amounts of IgG contaminating
the IgM fraction led to ingestion of sensitized erythrocytes . For example, E(IgM)
and E(IgM)C prepared with one IgM fraction (lot no . 40324 from Cordis
Laboratories) were ingested by nonactivated (andby activated) macrophages . To
determine the presence of IgG-contaminating IgM fractions, we coated E with a
subagglutinating titer of the IgM fraction and determined the ability of an
antibody prepared against the Fc fragment of rabbit IgG to agglutinate the
coated erythrocytes . The agglutination titer of anti-Fc IgG for E(IgM) prepared
with IgM lot no . 40324 was 1:128 . When this anti-Fc antibody failed to
agglutinate E(IgM), as was the case when IgM fraction (lot no . 30704 from Cordis
Laboratories) was used, minimal ingestion of E(IgM) or E(IgM)C by nonac-
tivated macrophages was observed, as indicated in Fig . 1 .
Ingestion of E(IgG) and .E(IgG)C by Actiuated Macrophages. Activated
macrophages were more efficient in phagocytizing IgG-coated erythrocytes than
their nonactivated counterparts. As shown in Fig. 2, 24-h and 48-h explanted
activated macrophages ingested both E(IgG) and E(IgG)C more avidly than did
nonactivated cells. The figure also shows that cultivation of nonactivated
macrophages under the described conditions also leads to more active ingestion
of IgG-coated erythrocytes, though the difference between activated and nonac-
tivated macrophages remains evident . During cultivation, morphological
changes also occur, principally better cell spreading, increased membrane
ruffling, and increased numbers of phase-dense cytoplasmic granules .1282 ALTERATION OF MACROPHAGECOMPLEMENT RECEPTOR FUNCTION
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Ingestion by activated and by nonactivated macrophages of IgG-coated sheep eryth-
rocytes prepared with and without complement . Lines represent the standard errors of the
means.
Modification of the Functional Activity of Complement Receptors upon
Macrophage Activation . While the phagocytosis of E(IgG) by macrophages is
quantitatively enhanced by thioglycollate medium activation, the functional
activity of complement receptors of activated macrophages is qualitatively
different from that of nonactivated macrophages. As shown in Fig . 1, nonac-
tivated macrophages do not ingest appreciable numbers of E(IgM)C . Activated
macrophages, however, ingest large numbers of E(IgM)C. Fig . 3 illustrates the
ingestion indices obtained when E(IgM) or E(IgM)C were incubated with
activated and with nonactivated macrophages which had been cultivated for 24
or 48 h . 66% of 24-h explanted activated macrophages ingested an average of 7 .8
E(IgM)C each (ingestion index of 518), while 89% of 48-h explanted activated
macrophages ingested an average of 11 .1 E(IgM)C each (ingestion index of 986) .
24-h and 48-h explanted nonactivated macrophages gave ingestion indices of 38
and 62, respectively . The difference between the results obtained with activated
and with nonactivated macrophages is highly significant3 with no overlapping
values . Similar results were obtained with 2-h and 72-h explanted activated and
nonactivated macrophages . Binding and ingestion of E and E(IgM) by activated
macrophages was low (ingestion index lower than 80), but was greater than the
binding observed with nonactivated macrophages .
Blocking of Fc Receptors by an Antimacrophage IgG Fraction .
￿
In order to
eliminate the participation of erythrocyte-bound IgG and receptors for the Fc
'P <0.001 by the Student's t test for both 24 and 48 h explanted macrophages.CELSOBIANCO, FRANKM . GRIFFIN, AND SAMUEL C . SILVERSTEIN
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Ingestion by activated and by nonactivated macrophages of IgM-coated sheep eryth-
rocytes prepared with and without complement . Lines represent the standard errors of the
means .
portion of IgG in the interaction of macrophages with complement-coated
erythrocytes, we blocked the Fc receptors ofthe macrophage plasma membrane
with antimacrophage IgG . As shown by Holland et al . (19), this antimacrophage
IgG blocks ingestion mediated by the Fc receptor, but has no effect upon inges-
tion of formaldehyde-treated erythrocytes .
We prepared antimacrophage IgG and its F(ab') 2 fragment, characterized the
binding of these immunoglobulin fractions to the macrophage surface, and
examined their effects upon the phagocytic capacities of the macrophage . Table I
summarizes the cytotoxic abilities of antimacrophage IgG and antimacrophage
F(ab'), Both antimacrophage IgG and antimacrophage F(ab') z bound to the
macrophage plasma membrane as measured by their abilities to directly or
indirectly [as is the case with antimacrophage F(ab') 2], mediate macrophage
lysis in the presence of hemolytic complement . The antigenic determinants on
the macrophage surface to which these antibodies are directed are not removed
by incubation of the macrophages with up to 1 mg/ml of trypsin for 30 min at
37°C .
Table II demonstrates the effects of antimacrophage IgG and of antimacro-
phage flab'), upon attachment and ingestion mediated by the Fc receptors and
by the complement receptors of nonactivated macrophages . Antimacrophage IgG
efficiently blocked binding and ingestion ofE(IgG) by macrophages, but had no
inhibitory effect upon the uptake of latex particles by these cells (data for latex
particles not shown) . The Fc receptor blocking activity of antimacrophage IgG
was dependent upon the presence of the Fc portion of the IgG molecule ; F(ab') 2
fragments of the same immunoglobulin did not inhibit binding or ingestion of
E(IgG) by macrophages. These results are identical to those of Holland et al .
(19) . Pretreatment of macrophages with an amount of antimacrophage IgG
sufficient to block completely Fc receptor-mediated binding and ingestion of1284
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TABLE I
Cytotoxic Assay of Antimacrophage IgG and Antimacrophage F(ab') Z
* Fresh rabbit serum diluted 1 :20 in medium 199 .
$ Determined by morphology and by trypan blue dye exclusion .
TABLE II
Influence of Antimacrophage IgG and of Trypsin Treatment of Nonactivated
Macrophages on the Attachment and Ingestion of Sensitized Erythrocytes
* Percent attachment and attachment index include figures for attachment plus ingestion . In other experiments,
attachment was evaluatedseparately by incubating macrophages with the various erythrocyte preparations under
conditions in which ingestion was inhibited (4°C or in the presence of NaF at 37°C) . The results obtained for
attachment werenot significantly different from those presented here .
E(IgG) had no inhibitory effect upon the binding of E(IgG)C or E(IgM)C to the
macrophage surface . Under these conditions, E(IgG)C and E(IgM)C were bound
to the macrophage surface presumably by complement receptors ; however, no
ingestion of E(IgG)C or E(IgM)C occurred . Thus, antimacrophage IgG blocked
specifically Fc receptor-mediated erythrocyte binding and ingestion but had no
effect upon binding mediated by the macrophage complement receptors .
Failure of Antimacrophage IgG to Block Complement-Mediated Ingestion by
Activated Macrophages . It was possible that phagocytosis of E(IgM)C by
activated macrophages was due to an enhanced capacity of these cells to
Erythrocyte
complex
Pretreatment
of macrophages
24-h explanted
Attachment*
Index
macrophages
Ingestion
% Index
48-h explanted
Attachment*
% Index
macrophages
Ingestion
Index
E(IgG) None 100 746 88 602 100 1620 97 1,576
Antimacrophage IgG 21 51 0 0 16 98 3 3
AntimacrophageF(ab') 2 100 786 92 736 ND ND ND ND
Trypsin 100 773 91 663 100 1,005 98 980
E(IgG)C None 100 928 90 786 100 1,474 95 1,394
Antimacrophage IgG 95 1,049 1 1 91 1,200 8 8
AntimacrophageF(ab'), 96 960 96 672 ND ND ND ND
Trypsin 100 780 96 720 100 1,000 96 960
E(IgM)C None 96 1,060 19 38 90 1,170 6 20
Antimacrophage IgG 91 892 0 0 91 939 2 2
Trypsin 11 15 2 2 0 0 1 1
E 1 1 0 0 2 4 0 0
E(IgM) 1 2 1 1 9 30 4 9
Macrophage
pretreatment
Antimacrophage
immunoglobulin
Complement* Lysis$
None IgG + >95
None IgG - <5
None F(ab'), + <5
None F(ab'), + SARIgG + >95
None SAR IgG + < 5
Trypsin IgG + >95
Trypsin F(ab'), + <5CELSO BIANCO, FRANK M. GRIFFIN, AND SAMUEL C. SILVERSTEIN
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recognize small quantities of IgG contaminating the anti-E IgM fraction used to
prepare E(IgM)C. The following experiments rule out this possibility . (a) The
anti-E IgM preparation used did not contain detectable quantities of IgG, as
assayed by the inability of antibody directed against the Fe fragment of IgG to
agglutinate E(IgM) or E(IgM)C. (b) Antimacrophage IgG blocked almost
completely the ingestion of E(IgG) by both 24-h and 48-h explanted activated
macrophages (Table III) . However, it only partially blocked the uptake of
E(IgM)C and E(IgG)C by 24-h explanted cells and had only a minimal inhibitory
effect upon phagocytosis of E(IgM)C and E(IgG)C by 48-h explanted macro-
phages . Ingestion of E(IgG)C by 24-h and 48-h explanted nonactivated macro-
phages was strongly inhibited by this antimacrophage IgG (Table II) . These
results confirm that phagocytosis of E(IgM)C by activated macrophages is
mediated by complement receptors, and not by Fc receptors, of the macrophage
plasma membrane.
Effect of Trypsin upon Complement-Mediated Attachment and Inges-
tion. Incubation of nonactivated macrophages with 1 mg/ml of trypsin for 30
min at 37°C abolished binding of E(IgM)C to the macrophage complement
receptors without detectable changes in macrophage binding and ingestion of
E(IgG) and E(IgG)C (Table 11). When 24-h or 48-h explanted activated
macrophages were trypsinized, they neither bound nor ingested E(IgM)C. The
identical trypsin sensitivity of complement receptors of activated and of
nonactivated macrophages further supports our contention that the ingestion of
E(IgM)C by activated macrophages is mediated by the complement receptor .
TABLE III
Ingestion of Sensitized Erythrocytes by Untreated and by Antimacrophage IgG-Treated
Activated Macrophages
* It should be noted that ingestion of E(IgG)C by untreated activated macrophages occurs via both Fe
receptors and by complement receptors. The drop in ingestion index of 24 h explanted cells from
1,840 to 363 is due chiefly to blocking of the participation of Fc receptors by antimacrophage IgG.
The figure of 363 should be compared with the ingestion index of 518for E(IgM)C when considering
blocking of complement receptors by antimacrophage IgG.
Erythrocyte
complex
Pretreatment with
antimacrophage IgG
24-h
Ingestion by
explanted
Index
macrophages
48-h
%
explanted
Index
E(IgG) - 82 1,412 100 2,280
+ 8 11 28 62
E(IgG)C - 100 1,840* 100 2,260
+ 71 363* 96 1,571
E(IgM)C - 66 518 89 986
+ 43 219 84 710
E 8 8 9 24
E(IgM) 14 49 26 651286
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Discussion
The in vitro cultivation of macrophages from the unstimulated mouse
peritoneal cavity results in marked enhancement of the capacities of these cells
to phagocytize IgG-coated erythrocytes . Nearly twice as many E(IgG) were
ingested by 48-h explanted nonactivated macrophages as by nonactivated cells
explanted for only 24 h (Fig . 2) . Thioglycollate-induced (activated) macrophages
are 1 .5-2 times as efficient as nonactivated macrophages in ingesting E(IgG), and
their capacity to phagocytize E(IgG) also increases with in vitro cultivation (Fig .
2 a and b) . Since we have not measured the time required for the ingestion of
individual erythrocytes by activated and by nonactivated macrophages, we
cannot be certain whether activated cells merely have an increased total
phagocytic capacity or whether they exhibit an increased rate of ingestion as
well .
Trypsin treatment of macrophages abolishes complement receptor binding
activity (2) but does not inhibit the capacity of these cells to phagocytize
E(IgG)C. Conversely, macrophages incubated with antimacrophage IgG [an
antibody preparation which specifically inhibits Fc receptor activity (Table II
and ref . 19) ], bind but do not ingest E(IgG)C . Thus the phagocytosis ofE(IgG)C
by nonactivated macrophages is mediated by the Fc receptor .
Erythrocytes coated with IgM are neither bound nor ingested by macrophages ;
erythrocytes coated with IgM and complement are bound by nonactivated
macrophages but are not ingested by them (Fig . 1, Table II). These results, and
those described above using antimacrophage IgG-treated macrophages, confirm
and extend the findings of Lay and Nussenzweig (2) and ofMantovani et al . (3) .
These latter authors showed that E(IgG)C incubated with F(ab) anti-IgG are
bound to, but not ingested by, mouse peritoneal macrophages. Thus, the com-
plement receptors of nonactivated mouse peritoneal macrophages do not medi-
ate erythrophagocytosis .
Macrophages induced by the intraperitoneal injection of thioglycollate me-
dium phagocytize erythrocytes coated withIgM and complement [E(IgM)C] (Fig.
3) . In this respect they differ qualitatively from nonactivated mouse macro-
phages . That the ingestion of E(IgM)C is mediated by C3b receptors on the
plasma membrane of activated macrophages was confirmed as follows: (a)
E(IgM) were neither bound nor ingested by activated macrophages . (b) The Fc
receptor blockade mediated by antimacrophage IgG did not interfere signifi-
cantly with the ingestion of either E(IgM)C or E(IgG)C . (c) Appropriate trypsin
treatment of activated macrophages abolished ingestion of E(IgM)C without
affecting the uptake of E(IgG) or E(IgG)C . Consequently, ingestion is not due to
an increased ability of activated macrophages to recognize the Fc portion ofIgG
or IgM .
Activated macrophages are more efficient in phagocytizing damaged erythro-
cytes . It was possible that complement fixation, even if not complete under the
conditions used, produced alterations in the erythrocyte membrane which could
be recognized by activated macrophages . To rule out this possibility, we (5)
further incubated E(IgM)C with fresh AKR mouse serum after complement
fixation . Under these conditions, C3b is converted to C3c and C3d ; C3d is inac-
tive as a ligand for macrophage complement receptors . These C3d-coated eryth-CELSO BIANCO, FRANKM. GRIFFIN, AND SAMUEL C. SILVERSTEIN
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rocytes were neither bound to nor igested by activated macrophages . We° also
incubated Cab-coated erythrocytes with a low concentration of trypsin at 37°C
or with a higher concentration at 4°C. Under these conditions as well, C3b is
rendered inactive as a ligand for macrophage C3b receptors, and the trypsin-
treated erythrocytes are neither bound nor ingested . For these reasons, it seems
unlikely that phagocytosis of E(IgM)C by activated macrophages is secondary to
complement-induced damage of the red cell surface .
C3b inactivator (KAF, conglutinogen activating factor) is a heat stable
enzyme present in normal serum which cleaves particle-bound C3b into a C3c
fragment which is released into the fluid phase and a C3d fragment which
remains bound to the particle (reviewed in 24). Many leukocytes bear receptors
for C3, and the interaction of antigen-antibody complexes with one or another
form of C3 has physiological importance in determining the fate of these
complexes . B lymphocytes have receptors for both C3b and C3d-bearing
erythrocytes (25, 26), while guinea pig (27) and human (25) polymorphonuclear
leukocytes, rabbit and human alveolar macrophages (6), and activated and
nonactivated mouse peritoneal macrophages (5) all have membrane receptors for
C3b only . Of these, only guinea pig and human polymorphonuclear leukocytes
(25,27) and activated mouse peritoneal macrophages phagocytize via their
complement receptors.
The mechanism responsible for the altered function of the complement
receptors of activated macrophages is not understood . The C3-binding activities
of C3 receptors on activated and nonactivated macrophages exhibit similar
trypsin sensitivities and requirements for the C3b fragment of the third
complement component . Thus, aside from differences in their functional
capacities, there is no reason to assume that the C3-binding activities of
activated and nonactivated macrophages are mediated by different membrane
receptors . It is possible that C3 receptors of activated macrophages are linked to
contractile elements in the macrophage cytoplasm, whereas C3 receptors of
nonactivated cells are not . It is also possible that the plasma membranes of
activated and of nonactivated macrophages contain different concentrations of
C3 receoptor molecules and that macrophages containing fewer than a threshold
number of receptors will bind but will not ingest complement-coated particles .
These two possibilities are not mutually exclusive .
The capacity of activated macrophages to phagocytize complement-coated
erythrocytes, and, by analogy, other complement-coated particles, raises several
issues relative to the in vivo significance of these findings . Particles coated with
early antibody (IgM) and exposed to plasma complement factors may be bound
but should not be ingested by nonactivated mouse peritoneal macrophages .
Inflammatory stimuli which cause macrophage activation will produce altera-
tions in the functional activity of the macrophage complement receptors leading
to the phagocytosis of complement-coated particles . In fact, the capacity of
activated macrophages to ingest C3b-coated particles provides an explanation at
the cellular level for the in vivo observations of Atkinson and Frank (28) . They
showed that IgM-coated homologous erythrocytes injected intravenously into
'Griffin, F.M ., J .A . Griffin, J.E . Leider, and S.C . Silverstein . Manuscript in preparation .1288
￿
ALTERATION OF MACROPHAGE COMPLEMENT RECEPTOR FUNCTION
normal guinea pigs were briefly sequestered by the liver [presumably as
E(IgM)C3b] and then released back into the circulation [presumably as
E(IgM)C3d] . The half-life of these erythrocytes was nearly the same as that of
nonopsonized erythrocytes . On the other hand, IgM-coated erythrocytes injected
intravenously into guinea pigs infected with BCG, a bacterium known for is
capacity to cause macrophage activation, were localized to the liver and were
presumably destroyed there . It is likely that these erythrocytes [E(IgM)C3b]
were ingested by the activated hepatic macrophages of these BCG-infected
animals . That early acting complement components were necessary for hepatic
localization of IgM-coated erythrocytes to occur was demonstrated in studies
with guinea pigs congenitally deficient in the fourth component ofcomplement .
In these animals, no erythrocyte trapping occurred (29) .
The observed association between activated macrophages and the phagocytic
capacity of their C3 receptors may be more than a fortuitous one in the handling
of obligatory intracellular parasites, such as Listeria monocytogenes and Brucella
abortus, which replicate efficiently in nonactivated macrophages but are killed
within activated macrophages (7) . Coating of these organisms with IgM and
complement might enhance their clearance by activated macrophages .
We do not know whether the activation of macrophages induced by the
intraperitoneal injection of thioglycollate medium is identical to the macrophage
activation described by Mackaness (7) and others (8-13) in chronic infections
and delayed hypersensitivity reactions. Preliminary results indicate that intra-
peritoneal injection of BCG or endotoxin elicit macrophages which also phagocy-
tize via their C3 receptors . Macrophages elicited by these agents exhibit a lower
intensity of C3 receptor-mediated phagocytosis than do cells elicited with
thioglycollate medium . Although the reasons for these differences are not yet
apparent, it is clear that macrophage activation can be achieved by a number of
agents and that macrophages exist in a variety of states or levels of activation .
The identification of markers for each of these states is a necessary prerequisite
for understanding the mechanism(s) underlying their induction and the role(s)
they play in macrophage physiology . In this context we propose that ingestion via
the C3b receptor is a simple, quick, and quantitative test for the identification of
activated macrophages .
Summary
We have examined the roles of Fc receptors and complement receptors in
mediating the interaction of sensitized sheep erythrocytes (E) with activated and
with nonactivated mouse peritoneal macrophages. Both activated and nonac-
tivated macrophages ingest IgG-coated erythrocytes [E(IgG) ] ; activated cells
ingest 1 .5-2 times as many E(IgG) as do nonactivated macrophages. Thus, there
is a quantitative difference in Fc receptor-mediated ingestion between activated
and nonactivated macrophages.
There is, however, a qualitative difference in function ofcomplement receptors
of activated and nonactivated macrophages . Nonactivated macrophages avidly
bind complement-coated E [E(IgM)C ], but do not ingest them to a significant
degree . Activated macrophages, on the other hand, bind and ingest E(IgM)C .
The possibility of Fe receptor participation in mediating ingestion of E(IgM)CCELSO BIANCO, FRANK M . GRIFFIN, AND SAMUEL C . SILVERSTEIN
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by activated macrophages was eliminated by blocking Fc receptors with an
antimacrophage IgG fraction . Activated macrophages treated with antimacro-
phage IgG did not ingest E(IgG) but did ingest both E(IgM)C and E(IgG)C .
Nonactivated macrophages treated with antimacrophage IgG did not interact at
all with E(IgG) . These cells bound, but did not ingest, E(IgG)C and E(IgM)C .
Complement receptor-mediated ingestion is a marker for macrophage activation
and may be physiologically important in the elimination of complement-coated
particles .
We gratefully acknowledge Ms . J . Griffin and Ms . E . Perez for excellent technical assistance and
Dr. Z . Cohn for helpful discussions .
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